GOLDMAN SACHS GROUP INC - GAMIDA CELL LTD ownership

GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 62 filers reported holding GAMIDA CELL LTD in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GAMIDA CELL LTD
ValueSharesWeighting
Q2 2023$273,255
+474.4%
141,583
+283.9%
0.00%
Q4 2022$47,570
-63.1%
36,876
-54.5%
0.00%
Q3 2022$129,000
+21.7%
81,099
+34.9%
0.00%
Q2 2022$106,000
+19.1%
60,102
+179.0%
0.00%
Q1 2022$89,000
-9.2%
21,544
-44.0%
0.00%
Q4 2021$98,000
-68.4%
38,482
-51.3%
0.00%
Q3 2021$310,000
+100.0%
79,025
+226.5%
0.00%
Q2 2021$155,000
-39.2%
24,205
-23.2%
0.00%
Q1 2021$255,000
+80.9%
31,518
+87.6%
0.00%
Q4 2020$141,00016,7970.00%
Other shareholders
GAMIDA CELL LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,318,207$26,844,0002.86%
Stonepine Capital Management, LLC 244,515$1,978,0001.07%
Healthcare Value Capital, LLC 50,000$405,0000.90%
Rock Springs Capital Management LP 2,100,300$16,991,0000.37%
Dorsey Wright & Associates 3,619$29,278,0000.34%
FIRST MIDWEST BANK TRUST DIVISION 302,487$2,447,0000.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 107,000$862,0000.23%
Guild Investment Management, Inc. 15,000$121,0000.13%
PREMIER ASSET MANAGEMENT LLC 86,464$699,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 973,575$7,876,0000.12%
View complete list of GAMIDA CELL LTD shareholders